Research article · 12 Jun 2025
Conference abstractPublished 2017
Polymer cancerostatics with a coiled coil motif targeted against murine leukemia
Institute of Macromolecular Chemistry, Czech Republic Institute of Molecular Genetics, Czech Republic Institute of Microbiology, Czech Republic
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Coiled coil is a common structural motif in many natural proteins. It can be also utilized in design and preparation of the drug delivery systems for non-covalent connection of two macromolecules. In this work, two different pairs of peptides forming coiled coil heterodimers were designed, synthesized and characterized. While the peptide sequences (VAALEKE)4 (peptide EKE) and (VAALKEK)4 (peptide KEK) form a coiled coil heterodimer with random orientation of the peptide chains, (IAALESE)2- IAALESKIAALESE (peptide ESE) and IAALKSKIAALKSE-(IAALKSK)2 (peptide KSK) tend to adopt an anti-parallel orientation of the chains. The orientation of the peptide chains in the coiled coil heterodimers was determined using fluorescence spectroscopy with fluorescence resonance energy transfer labels attached to the ends of the peptides. Both coiled coil heterodimers were used for attachment of a recombinant targeting protein – a single-chain antibody fragment of B1 antibody – to a polymer drug conjugate based on N-(2-hydroxypropyl)-methacrylamide bearing an anti-cancer drug pirarubicin (THP). Both targeted polymer conjugates exhibited a markedly increased cytotoxic activity in vitro against BCL1 leukemia cells expressing the corresponding antigen compared to the non-targeted polymer drug conjugate. The targeted conjugate containing KSK/ESE coiled coil heterodimer (with the anti-parallel orientation) showed about 2-times higher cytotoxic activity and approximately 4-times higher cell-binding activity (as determined by flow cytometry) than the targeted conjugate with KEK/EKE anchor. In vivo therapeutic activity of the actively targeted polymer- THP conjugate (with KSK/ESE heterodimer) in mice bearing BCL1 leukemia was significantly higher (in terms of the survival time) compared with both the non-targeted polymer-pirarubicin conjugate and the parent drug. It was clearly demonstrated that the coiled coil heterodimers can be utilized for non-covalent attachment of recombinant targeting proteins to polymer-drug conjugates thus enabling preparation of a new generation of actively targeted macromolecular cancerostatics.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Michal Pechar”
- BylineArticles whose byline prints “Robert Pola”
- BylineArticles whose byline prints “Olga Janouskova”
- BylineArticles whose byline prints “Irena Sieglova”
- BylineArticles whose byline prints “Vlastimil Kral”
- BylineArticles whose byline prints “Milan Fabry”
- BylineArticles whose byline prints “Barbora Tomalova”
- BylineArticles whose byline prints “Marek Kovar”
